ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 |

Results: 25

PRIOR TREATMENT WITH ALPHA-INTERFERON DOES NOT ADVERSELY AFFECT THE OUTCOME OF ALLOGENEIC BMT IN CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA

Authors: ZUFFA E BANDINI G BONINI A SANTUCCI MA MARTINELLI G ROSTI G TESTONI N ZACCARIA A TURA S

Citation: E. Zuffa et al., PRIOR TREATMENT WITH ALPHA-INTERFERON DOES NOT ADVERSELY AFFECT THE OUTCOME OF ALLOGENEIC BMT IN CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA, Haematologica, 83(3), 1998, pp. 231-236

BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/

Authors: BONINI A BANDINI G ROSTI G RONDELLI D TESTONI N REMIDDI C MOTTA MR RIZZI S MANGIANTI S CAMPANINI E ZUFFA E TURA S

Citation: A. Bonini et al., BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/, Bone marrow transplantation, 21(11), 1998, pp. 1085-1089

LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA

Authors: TURA S ROSTI G DEVIVO A BONIFAZI F FIACCHINI M BACCARANI M RUSSO D FANIN R ZUFFA E MONTEFUSCO E

Citation: S. Tura et al., LONG-TERM FOLLOW-UP OF THE ITALIAN TRIAL OF INTERFERON-ALPHA VERSUS CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOID-LEUKEMIA, Blood, 92(5), 1998, pp. 1541-1548

INTERFERON-ALFA VERSUS CHEMOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - A METAANALYSIS OF 7 RANDOMIZED TRIALS

Authors: DELANNOY A KLUINNELEMANS JC LOUWAGIE A STRYCKMANNS P SUCIU S HEHLMANN R HEIMPEL H HASFORD J ZUFFA E BACCARANI M TURA S OHNISHI K OHNO R ALLAN N SHEPHERD P BROUSTET A ALISON R CLARKE M DUONG H GRAY R GREAVES E PETO R RICHARDS S SINCLAIR D WHEATLEY K

Citation: A. Delannoy et al., INTERFERON-ALFA VERSUS CHEMOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - A METAANALYSIS OF 7 RANDOMIZED TRIALS, Journal of the National Cancer Institute, 89(21), 1997, pp. 1616-1620

FLANG (FLUDARABINE PLUS CYTOSINE-ARABINOSIDE PLUS NOVANTRONE PLUS G-CSF) INDUCES PARTIAL REMISSION IN LYMPHOID BLAST-TRANSFORMATION OF PH(+) CHRONIC MYELOGENOUS LEUKEMIA

Authors: MARTINELLI G TESTONI N ZUFFA E VISANI G ZINZANI PL ZACCARIA A FARABEGOLI P ARPINATI M AMABILE M TURA S

Citation: G. Martinelli et al., FLANG (FLUDARABINE PLUS CYTOSINE-ARABINOSIDE PLUS NOVANTRONE PLUS G-CSF) INDUCES PARTIAL REMISSION IN LYMPHOID BLAST-TRANSFORMATION OF PH(+) CHRONIC MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 173-176

AUTOIMMUNE MEDIATED THROMBOCYTOPENIA ASSOCIATED WITH THE USE OF INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA

Authors: ZUFFA E VIANELLI N MARTINELLI G TAZZARI P CAVO M TURA S

Citation: E. Zuffa et al., AUTOIMMUNE MEDIATED THROMBOCYTOPENIA ASSOCIATED WITH THE USE OF INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 533-535

THE INFLUENCE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) ON SURVIVAL IN CHRONIC MYELOID-LEUKEMIA (CML) - A NATIONAL SURVEY IN ITALY

Authors: BACCARANI M BANDINI G ARCESE W ZUFFA E

Citation: M. Baccarani et al., THE INFLUENCE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) ON SURVIVAL IN CHRONIC MYELOID-LEUKEMIA (CML) - A NATIONAL SURVEY IN ITALY, Experimental hematology, 24(9), 1996, pp. 660-660

ALPHA-IFN TREATMENT OF CML - CLINIC, CYTOGENETIC AND MOLECULAR UPDATE

Authors: ZACCARIA A ZUFFA E ROSTI G BACCARANI M TURA S

Citation: A. Zaccaria et al., ALPHA-IFN TREATMENT OF CML - CLINIC, CYTOGENETIC AND MOLECULAR UPDATE, Experimental hematology, 24(9), 1996, pp. 719-719

INTERFERON-ALPHA IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA - A SUMMARY AND AN UPDATE OF THE ITALIAN STUDIES

Authors: ROSTI G DEVIVO A ZUFFA E BACCARANI M

Citation: G. Rosti et al., INTERFERON-ALPHA IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA - A SUMMARY AND AN UPDATE OF THE ITALIAN STUDIES, Bone marrow transplantation, 17, 1996, pp. 11-13

NEUTRALIZING ANTI-INTERFERON-ALPHA ANTIBODIES AND RESPONSE TO TREATMENT IN PATIENTS WITH PH(-LEUKEMIA SEQUENTIALLY TREATED WITH RECOMBINANT(ALPHA-2A) AND LYMPHOBLASTOID INTERFERON-ALPHA() CHRONIC MYELOID)

Authors: RUSSO D CANDONI A ZUFFA E MINISINI R SILVESTRI F FANIN R ZAJA F MARTINELLI G TURA S BOTTA G BACCARANI M

Citation: D. Russo et al., NEUTRALIZING ANTI-INTERFERON-ALPHA ANTIBODIES AND RESPONSE TO TREATMENT IN PATIENTS WITH PH(-LEUKEMIA SEQUENTIALLY TREATED WITH RECOMBINANT(ALPHA-2A) AND LYMPHOBLASTOID INTERFERON-ALPHA() CHRONIC MYELOID), British Journal of Haematology, 94(2), 1996, pp. 300-305

A NEW METHOD OF IN-CELL REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION FOR THE DETECTION OF BCR ABL TRANSCRIPT IN CHRONIC MYELOID-LEUKEMIAPATIENTS/

Authors: TESTONI N MARTINELLI G FARABEGOLI P ZACCARIA A AMABILE M RASPADORI D PELLICONI S ZUFFA E CARBONI C TURA S

Citation: N. Testoni et al., A NEW METHOD OF IN-CELL REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION FOR THE DETECTION OF BCR ABL TRANSCRIPT IN CHRONIC MYELOID-LEUKEMIAPATIENTS/, Blood, 87(9), 1996, pp. 3822-3827

COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA

Authors: KATTAN MW INOUE Y GILES FJ TALPAZ M OZER H GUILHOT F ZUFFA E HUBER SL BECK JR

Citation: Mw. Kattan et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Annals of internal medicine, 125(7), 1996, pp. 541

DOES THE TYPE OF BCR ABL JUNCTION PREDICT THE SURVIVAL OF PATIENTS WITH PH(1)-POSITIVE CHRONIC MYELOID-LEUKEMIA/

Authors: ZACCARIA A MARTINELLI G TESTONI N ZUFFA E FARABEGOLI P RUSSO D GUERRASIO A TURA S

Citation: A. Zaccaria et al., DOES THE TYPE OF BCR ABL JUNCTION PREDICT THE SURVIVAL OF PATIENTS WITH PH(1)-POSITIVE CHRONIC MYELOID-LEUKEMIA/, Leukemia & lymphoma, 16(3-4), 1995, pp. 231-236

CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/

Authors: BACCARANI M TURA S RUSSO D BACCARANI M ZACCARIA A SAGLIO G GUERRASIO A MARTINELLI G ZUFFA E TESTONI N FARABEGOLI P ZAMAGNI MD FANIN R DAMIANI D DEMILIO A BATTISTA R SPECCHIA G LISO V DITUCCI A BROCCIA G MONTEFUSCO E MANDELLI F RAMBALDI A BARBUI T BODENIZZA CA CAROTENUTO M ROTONDO SG AMBROSETTI A PERONA G LUCIANO L ROTOLI B RONCO F NOBILE F TABILIO A LIBERATI A MARTELLI M GRIGNANI F PARDINI S LONGINOTTI M GENTILINI I COSER P LEONI F CIOLLI S MORRA E BERNASCONI C FERRERO D PILERI A LEONI P DANIELI G ABBADESSA A BRUZZESE L TRINGALI S CARONIA F GALIENI P DISPENSA E NOVARINO A CAPUCCI A IZZI T NOSARI A PIZZUTI M RICCIUTI F VASINO AC RESEGOTTI L CAPALDI A GIOVANNELLI E

Citation: M. Baccarani et al., CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/, Leukemia, 9(10), 1995, pp. 1648-1652

BINDING OF BCR ABL JUNCTIONAL PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I-B35 MOLECULES - RELATIONSHIP BETWEEN ANTIGEN DEFECTIVE CELL-LINES AND HLA FREQUENCIES IN CML PATIENTS/

Authors: MARTINELLI G ZACCARIA A SAGLIO G ZUFFA E FARABEGOLI P TESTONI N CONTE R TURA S

Citation: G. Martinelli et al., BINDING OF BCR ABL JUNCTIONAL PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I-B35 MOLECULES - RELATIONSHIP BETWEEN ANTIGEN DEFECTIVE CELL-LINES AND HLA FREQUENCIES IN CML PATIENTS/, Leukemia, 9(10), 1995, pp. 1795-1796

THE ITALIAN AND THE GERMAN CHRONIC MYELOID-LEUKEMIA TRIALS WITH INTERFERON-ALFA - A COMPARATIVE-ANALYSIS

Authors: HASFORD J BACCARANI M HEHLMANN R TURA S ANSANI H ZUFFA E

Citation: J. Hasford et al., THE ITALIAN AND THE GERMAN CHRONIC MYELOID-LEUKEMIA TRIALS WITH INTERFERON-ALFA - A COMPARATIVE-ANALYSIS, Blood, 86(10), 1995, pp. 1063-1063

APOPTOSIS INDUCTION WITH FLUDARABINE ON FRESHLY ISOLATED CHRONIC MYELOID-LEUKEMIA CELLS

Authors: ZINZANI PL BUZZI M FARABEGOLI P MARTINELLI G TOSI P ZUFFA E VISANI G TESTONI N SALVUCCI M BENDANDI M ZACCARIA A TURA S

Citation: Pl. Zinzani et al., APOPTOSIS INDUCTION WITH FLUDARABINE ON FRESHLY ISOLATED CHRONIC MYELOID-LEUKEMIA CELLS, Haematologica, 79(2), 1994, pp. 127-131

INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA

Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E

Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825

LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP

Authors: CERVANTES F ROBERTSON JE ROZMAN C BACCARANI M TURA S GOMEZ GA BRAUN TJ CLARKSON BD PEREIRA A ZACCARIA A ZUFFA E MANDELLI F ALIMENA G MONTEFUSCO E RUSSO D FANIN R GRIGNANI F MARTELLI MF MORRA E BERNASCONI C CAJOZZO A PERONA G AMBROSETTI A LEONI P LOMBARDO M DELFINI C TORLONTANO G PORCELLINI A DEMILIO A BATTISTA R LEONI F GUGLIELMO P GIUSTOLISI R DECATALDO F NOSARI A RIZZOLI V MANGONI M CARNEVALI C LISO V SPECCHIA G BAJETTA E BROCCIA G DITUCCI A BUSINCO A BRUZZESE L ABADESA A LANZI E ALBERTI A NERI A RONCO F TONATO M GRIFONI V

Citation: F. Cervantes et al., LONG-TERM SURVIVORS IN CHRONIC GRANULOCYTIC-LEUKEMIA - A STUDY BY THEINTERNATIONAL CGL PROGNOSIS STUDY-GROUP, British Journal of Haematology, 87(2), 1994, pp. 293-300

PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION

Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E

Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71

WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT

Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M

Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89

INTERFERON-ALPHA EFFECTS ON STROMAL COMPARTMENT OF NORMAL AND CHRONICMYELOID-LEUKEMIA HEMATOPOIESIS

Authors: SANTUCCI MA SOLIGO D PILERI S ZUFFA E TESTONI N TURA S

Citation: Ma. Santucci et al., INTERFERON-ALPHA EFFECTS ON STROMAL COMPARTMENT OF NORMAL AND CHRONICMYELOID-LEUKEMIA HEMATOPOIESIS, Leukemia & lymphoma, 11, 1993, pp. 113-118

TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE

Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M

Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157

KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML

Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E

Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280

THE TYPE OF BCR ABL JUNCTION DOES NOT PREDICT THE SURVIVAL OF PATIENTS WITH PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA/

Authors: ZACCARIA A MARTINELLI G BUZZI M TESTONI N FARABEGOLI P ZUFFA E ZAMAGNI MD RUSSO D BACCARANI M AMBROSETTI A GUERRASIO A SAGLIO G TURA S

Citation: A. Zaccaria et al., THE TYPE OF BCR ABL JUNCTION DOES NOT PREDICT THE SURVIVAL OF PATIENTS WITH PH1-POSITIVE CHRONIC MYELOID-LEUKEMIA/, British Journal of Haematology, 84(2), 1993, pp. 265-268

Risultati: 1-25 |